EUVIMEDEUVIMED entdecken
Übersichtsarbeit

CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy

Mario K Shammas iD, Tzu-Hsiang Huang, Derek P Narendra iD

Biochemical Society Transactions · 2023

DOI: 10.1042/bst20221365 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2023. Verfasst von Mario K Shammas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Inherited Disorders Unit, Neurogenetics Branch, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, National In…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Parkinson Disease. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the last decade, dominant mutations in the mitochondrial protein CHCHD10 (p.R15L and p.S59L) and its paralog CHCHD2 (p.T61I) were shown to cause familial amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), respectively, with phenotypes that often resemble the idiopathic forms of the diseases. Different mutations in CHCHD10 cause additional neuromuscular disorders, including the lower motor neuron disease Spinal Muscular Atrophy Jokela type (SMAJ) (p.G66V) and autosomal dominant isolated mitochondrial myopathy (IMMD) (p.G58R). Modeling these disorders is revealing how mitochondrial dysfunction may drive ALS and PD pathogenesis by a gain of function mechanism, driven by protein misfolding of CHCHD2 and CHCHD10 into toxic species. It is also laying the groundwork for precision therapy of CHCHD2/CHCHD10-related neurodegeneration. In this review, we address the normal function of CHCHD2 and CHCHD10, the mechanisms of their disease pathogenesis, the strong genotype–phenotype correlations that have emerged for CHCHD10, and potential therapeutic strategies for these disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisParkinson DiseaseHumansDNA-Binding ProteinsTranscription FactorsMitochondriaMutationMitochondrial Proteins

Stichwörter der Autor:innen

Parkinson's diseaseamyotrophic lateral sclerosisantisense oligomitochondrial dysfunctionstress response

Substanzen

DNA-Binding ProteinsTranscription FactorsMitochondrial ProteinsCHCHD10 protein, humanCHCHD2 protein, human

Autor:innen und Institutionen

  • Inherited Disorders Unit, Neurogenetics Branch, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, U.S.A.

ORCID-Profile: Mario K Shammas, Derek P Narendra

Förderung

  • Intramural NIH HHS

Zitieren

APA

Shammas, M. K., Huang, T. H., & Narendra, D. P. (2023). CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy. Biochemical Society Transactions. https://doi.org/10.1042/bst20221365

Vancouver

Shammas MK, Huang TH, Narendra DP. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy. Biochemical Society Transactions. 2023. doi:10.1042/bst20221365

BibTeX
@article{Shammas2023,
  author = {Shammas, Mario K and Huang, Tzu-Hsiang and Narendra, Derek P},
  title = {CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy},
  journal = {Biochemical Society Transactions},
  year = {2023},
  doi = {10.1042/bst20221365}
}
Kostenlos starten →